Team, M. T. N. 0. S., Hoesley, C. J., Chen, B. A., Anderson, P. L., Dezzutti, C. S., Strizki, J., . . . Piper, J. (2019). Phase 1 Safety and Pharmacokinetics Study of MK-2048/Vicriviroc (MK-4176)/MK-2048A Intravaginal Rings. Clinical Infectious Diseases, 68(7), 1136.
Chicago Style (17th ed.) CitationTeam, Microbicide Trials Network 027 Study, et al. "Phase 1 Safety and Pharmacokinetics Study of MK-2048/Vicriviroc (MK-4176)/MK-2048A Intravaginal Rings." Clinical Infectious Diseases 68, no. 7 (2019): 1136.
MLA (8th ed.) CitationTeam, Microbicide Trials Network 027 Study, et al. "Phase 1 Safety and Pharmacokinetics Study of MK-2048/Vicriviroc (MK-4176)/MK-2048A Intravaginal Rings." Clinical Infectious Diseases, vol. 68, no. 7, 2019, p. 1136.
Warning: These citations may not always be 100% accurate.
Visit our Citation Styles guide for help on properly citing sources.
Visit our Citation Styles guide for help on properly citing sources.